Allogene Therapeutics Inc. (NASDAQ: ALLO) will host a conference call on April 13, 2026, to present interim futility analysis data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE